Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.870
+0.020 (0.70%)
At close: Jul 17, 2026, 4:00 PM EDT
2.931
+0.061 (2.11%)
After-hours: Jul 17, 2026, 7:59 PM EDT
Altimmune Market Cap
Altimmune has a market cap or net worth of $558.14 million as of July 17, 2026. Its market cap has increased by 64.63% in one year.
Market Cap
558.14M
Enterprise Value
262.45M
1-Year Change
64.63%
Ranking
Category
Stock Price
$2.87
ChartMarket Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $558.14M, a decrease of -74.53%. That is a compound annual growth rate of -13.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 558.14M | 41.64% |
| Dec 31, 2025 | 394.05M | -23.16% |
| Dec 31, 2024 | 512.81M | -15.16% |
| Dec 29, 2023 | 604.45M | -25.23% |
| Dec 30, 2022 | 808.45M | 122.62% |
| Dec 31, 2021 | 363.14M | -12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 592.95M |
| Shattuck Labs | 577.40M |
| 4D Molecular Therapeutics | 574.52M |
| Prime Medicine | 565.33M |
| Relmada Therapeutics | 549.62M |
| Contineum Therapeutics | 532.01M |
| Assembly Biosciences | 531.30M |
| Verastem | 529.88M |